To study the severity of bleeding during Transbronchial lung biopsy.
Not Applicable
Completed
- Conditions
- Health Condition 1: J95- Intraoperative and postproceduralcomplications and disorders of respiratory system, not elsewhere classified
- Registration Number
- CTRI/2019/05/019147
- Lead Sponsor
- Fluid Research Fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 289
Inclusion Criteria
All male and female patients above the age of 18 years presenting to the department of Pulmonary Medicine department of CMC for Transbronchial Lung biopsy
Exclusion Criteria
-Known bleeding diathesis
-Pregnant women
-Thrombocytopenia
-Chronic Kidney Disease
-Chronic Liver Disease patients
-Patients on Chemotherapy
-Post Lung transplant
-History of significant bleeding -post operative or trauma
-History of severe epistaxis, GI bleed, hematuria, menorrhagia, petechiae,
-Treatment with Anticoagulants
-Patients in sepsis with shock or disseminated intravascular coagulation
-Patients with low respiratory reserve
-All patients who do not consent to the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the incidence and severity of endobronchial bleeding during Transbronchial lung biopsy (TBLB) procedure.Timepoint: May 2019 to June 2020
- Secondary Outcome Measures
Name Time Method 1.To assess the etiology of moderate to severe endobronchial bleeding in patients undergoing transbronchial biopsy procedure, in the department of pulmonary medicine. <br/ ><br>2.To find the difference in proportion of patients with significant endobronchial bleeding during TBLB procedure performed for different lung pathologies. <br/ ><br>Timepoint: May 2019 to June 2020